Innoviva, Inc.

Insider Reports History

Entity
Company
Location
1350 Old Bayshore Highway, Suite 400, Burlingame, CA
Signature
INNOVIVA, INC. By: /s/ Pavel Raifeld Name: Pavel Raifeld Title: Chief Executive Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Innoviva, Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Entasis Therapeutics Holdings Inc. 10%+ Owner Common Stock 29.3M $64.4M $2.20 Jul 11, 2022 Indirect
Entasis Therapeutics Holdings Inc. 10%+ Owner Common Stock 18.7M $41.1M $2.20 Jul 8, 2022 Direct
Entasis Therapeutics Holdings Inc. 10%+ Owner Warrants to Purchase Common Stock 18.7M $37.3M $2.00 Jul 8, 2022 Direct
Entasis Therapeutics Holdings Inc. 10%+ Owner Warrants to Purchase Common Stock 10M $20M $2.00 Jul 8, 2022 Indirect
Entasis Therapeutics Holdings Inc. 10%+ Owner Convertible Promissory Note 0 Jul 8, 2022 Indirect
Armata Pharmaceuticals, Inc. Director, 10%+ Owner Convertible Debt convertible into Common Stock $30M Jan 10, 2023 Indirect

Insider Reports Filed by Innoviva, Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARMP Armata Pharmaceuticals, Inc. Jan 10, 2023 1 $30M 4 Jan 12, 2023 Director, 10%+ Owner
ETTX Entasis Therapeutics Holdings Inc. Jul 8, 2022 2 $42.4M 4 Jul 13, 2022 10%+ Owner
ARMP Armata Pharmaceuticals, Inc. Mar 31, 2022 2 $26.9M 4 Apr 1, 2022 Director, 10%+ Owner
ETTX Entasis Therapeutics Holdings Inc. Feb 18, 2022 2 $0 4 Feb 23, 2022 10%+ Owner
ARMP Armata Pharmaceuticals, Inc. Feb 9, 2022 2 $27.1M 4 Feb 11, 2022 Director, 10%+ Owner
ARMP Armata Pharmaceuticals, Inc. Oct 29, 2021 1 $4M 4 Nov 1, 2021 Director, 10%+ Owner
ETTX Entasis Therapeutics Holdings Inc. Jun 11, 2021 2 $25.1M 4 Jun 11, 2021 10%+ Owner
ETTX Entasis Therapeutics Holdings Inc. May 3, 2021 2 $14.9M 4 May 20, 2021 10%+ Owner